300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Retail
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Theatre
Beauty
Infrastructure
Medical
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Recruiting
Life Science
Wine and Spirits
Food and Beverage
Publishing
Web3
Music
Art
Real Estate
Sporting Goods
Manufacturing
Financial Services
Social Media
Franchise
Mobile Advertising
Digital Media
Non Profit
Internet
Android
FinTech
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Finance
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Brazil
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Canada
Indonesia
United Kingdom
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Bangladesh
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Finland
Belize
Hungary
Grenada
Israel
Italy
Iceland
Cambodia
Honduras
Lithuania
Belarus
Liechtenstein
Peru
Lebanon
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Claus Berner Møller, Vice President at ATP

Claus Berner Møller

Vice President @ ATP

Copenhagen, Denmark

Claus Berner Møller is a Vice President, Danish Equities at ATP. Claus Berner Møller attended the University of Copenhagen.

Total investments:
3
Last investment:
Lead investor:
33%

Last updated:

Industries Claus Berner Møller invests in

Health CareLife ScienceMedical DevicePharmaceuticalHealth Diagnostics

Stages Claus Berner Møller invests in

Series BFunding Round

Countries Claus Berner Møller invests in

Denmark

Investment Focus

Industry

  • Health Care 1 (33%)
  • Life Science 1 (33%)
  • Medical Device 1 (33%)
  • Pharmaceutical 1 (33%)
  • Health Diagnostics 1 (33%)

Stage

  • Series B 1 (33%)
  • Funding Round 1 (33%)

Investments

CompanyDescriptionRoundLinks
MedTrace Pharma MedTrace Pharma
MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse. $19M / Sep 21, 2023
MedTrace Pharma MedTrace Pharma
MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse. May 12, 2021
MedTrace Pharma MedTrace Pharma
MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse. $29.2M / Series B / May 12, 2021

Co-Investors

ATP

About ATP

VC Fund

ATP is a self-governing institution, established by the Folketing by law in 1964. ATP's Board of Directors consists of equal representatives of employers and employees and an independent chairman of the board. The ATP Group has approx. 3,000 employees. ATP is headquartered in Hillerød, customer service centers in Frederikshavn, Holstebro,Haderslev, Vordingborg, Lillerød and Hillerød, as well as offices in Copenhagen, Allerød and New York.

ATP Contacts

NameEmailPhoneSocials
Claus Berner Møller
Claus Berner Møller Vice President

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Open ATP full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Retail
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Theatre
Beauty
Infrastructure
Medical
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Recruiting
Life Science
Wine and Spirits
Food and Beverage
Publishing
Web3
Music
Art
Real Estate
Sporting Goods
Manufacturing
Financial Services
Social Media
Franchise
Mobile Advertising
Digital Media
Non Profit
Internet
Android
FinTech
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Finance
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Brazil
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Canada
Indonesia
United Kingdom
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Bangladesh
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Finland
Belize
Hungary
Grenada
Israel
Italy
Iceland
Cambodia
Honduras
Lithuania
Belarus
Liechtenstein
Peru
Lebanon
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Claus Berner Møller invest in?

Claus Berner Møller invests primarily in Health Care, Life Science and Medical Device startups, most often at Series B and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Claus Berner Møller last invest?

The most recent investment recorded for Claus Berner Møller closed in Sep 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Claus Berner Møller Claus Berner Møller Find email